Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate (Q42956746)

11 November 2017

Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate (English)

1 reference

11 November 2017

1 reference

Jiří Vencovský

4

0 references

Paul P Tak

7

object named as

Paul P Tak

1 reference

11 November 2017

Daniëlle M Gerlag

1

1 reference

11 November 2017

Sally Hollis

2

1 reference

11 November 2017

Mark Layton

3

1 reference

11 November 2017

Zoltán Szekanecz

5

1 reference

11 November 2017

Martin Braddock

6

1 reference

11 November 2017

ESCAPE Study Group

8

1 reference

11 November 2017

language of work or name

1 reference

1 November 2010

1 reference

11 November 2017

Arthritis & Rheumatology

1 reference

11 November 2017

62

1 reference

11 November 2017

11

1 reference

11 November 2017

3154-3160

1 reference

Chemokines in joint disease: the key to inflammation?

11 November 2017

1 reference

Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis

21 January 2018

1 reference

Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis

21 January 2018

1 reference

Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis

21 January 2018

1 reference

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

21 January 2018

1 reference

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D).

21 January 2018

1 reference

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

21 January 2018

1 reference

Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.27652

1 reference

11 November 2017

1 reference